RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 1999; 82(06): 1780-1781
DOI: 10.1055/s-0037-1614922
DOI: 10.1055/s-0037-1614922
Letters to the Editor
The Methylenetetrahydrofolate Reductase Gene C677T Mutant and Ischemic Stroke in Sickle Cell Disease
Autoren
Weitere Informationen
Publikationsverlauf
Received
30. Oktober 1998
Accepted after resubmission
29. Juni 1999
Publikationsdatum:
10. Dezember 2017 (online)
-
References
- 1 Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Noohr JW, Wethers DL, Pegelow CH, Gill FM. Cerebrovascular Accidents in Sickle Cell Disease: Rates and Risk Factors. Blood 1998; 91: 288-94.
- 2 Houston PE, Rana S, Skehsaria S, Perlin E, Kim KS, Castro OL. Homocysteine in Sickle Cell Disease: Relationship to Stroke. Amer J Med 1997; 102: 192-6.
- 3 Welch GE, Loscalzo J. Homocysteine and Atherothrombosis. NEJM 1998; 338: 1042-50.
- 4 Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995; 346: 1395-8.
- 5 Rosenblatt DS. Inherited disorders of folate transport and metabolism. In Scriver CR, Beaudet AL, Sly WS, Valle D. (eds). The metabolic and molecular basis of inherited disease. 7th edition. New York: McGraw Hill; 1995. pp 3111-28.
- 6 Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heurvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics 1995; 10: 111-3.
- 7 Stevenson RE, Schwartz CE, Du Y, Adams MJ. Differences in methylenetetrahydrofolate reductase genotype frequencies, between whites and blacks. Am J Hum Genet 1997; 60: 229-30.
- 8 Franco RF, Araujo AG, Guerreiro JF, Elion J, Zago MA. Analysis of the 677 C → T mutation of the methylenetetrahyrofolate reductase gene in different ethnic groups. Thromb Haemost 1998; 79: 119-21.
- 9 Kang S, Zhou J, Wong PWK, Kowalisyn J, Strokosch G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 1988; 43: 414-21.
- 10 Guttormsen AB, Ueland PM, Nesthus I, Nygard O, Schneede J, Vollset S, Refsum H. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia. J Clin Invest 1996; 98: 2174-83.
- 11 Brattstrom L, Wilcken DEL, Ohrvik J, and Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The result of a metaanalysis. Circulation 1998; 98: 2520-6.
- 12 Zimmerman SA, Ware RE. Inherited DNA mutations contributing to thrombotic complications in patients with sickle cell disease. Amer J Hemat 1998; 59: 267-72.
- 13 Kutlar F, Tural C, Park D, Markowitz RB, Woods KF, Kutlar A. 5,10-methylenetetrahydrofolate reductase C677T gene mutation as a candidate risk factor for avascular necrosis in patients with sickle cell disease. Blood 1998; 92: 695A.
- 14 Hebbel RP, Vercellotti GM. The endothelial biology of sickle cell disease: A Review. J Lab Clin Med 1997; 288-93.
- 15 Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter D, Fuchs C, Willett W, Selhub J, Hennekens C, Rozen R. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997; 57: 1098-102.